Add Yahoo as a preferred source to see more of our stories on Google. Apr. 9—(StatePoint) Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks ...

Please provide your email address to receive an email when new articles are posted on . New COVID-19 vaccines for 2024-2025 will target JN.1 variants of SARS-CoV-2. A newly approved 21-valent ...

The ACIP recommends vaccination for all adults aged 50 years and older who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown. The Centers ...

Please provide your email address to receive an email when new articles are posted on . Although vaccines have reduced the burden of pneumococcal disease, pneumonia due to Streptococcus pneumoniae and ...

Add Yahoo as a preferred source to see more of our stories on Google. NEW YORK (AP) — A scientific panel on Wednesday recommended that people 50 and older get a shot against bacteria that can cause ...

With an expanded usage recommendation from the CDC's Advisory Committee on Immunization Practices (ACIP), pneumococcal conjugate vaccines from Pfizer and Merck are poised to add millions more eligible ...

The CDC has issued its updated 2026 adult immunization schedule, adding refined RSV vaccine eligibility, annual COVID-19 boosters, and clarified pneumococcal options. The changes aim to simplify ...

The U.S. Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease. The agency's earlier ...

—Among adults, coverage and preventable burdens were lowest for pneumococcal conjugate vaccine (PCV) 15 and highest for PCV31, with PCV21 preventing notable burdens of both acute respiratory ...

The Centers for Disease Control and Prevention (CDC) now recommends that American adults over the age of 50 receive the pneumococcal conjugate vaccine, or PCV. The report with the updated ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...

Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to know that there are steps you ...